Twitter Beğeni Hilesi

"R&D is key to MedTech growth. To unlock its potential, we need a supportive environment that fosters innovation. With the right resources, India can lead in cutting-edge healthcare solutions. – Mr. Awadhesh Kumar Choudhary, Sr Economic Advisor, Dept of Pharmaceuticals

"Requesting a single window for the MedTech sector to streamline workflows and boost efficiency. This will enhance innovation and quality in both manufacturing and imports. – Mr. Atul Grover, Managing Director, Becton Dickinson India Pvt Ltd

To achieve our vision of #ViksitBharat by 2047, we can’t be working in silos. We must collaborate across industry, academia, and government. Embracing PPPs within the country as well as with other countries for both financial and knowledge resources will help align our vision. We

“India needs value-based procurement tailored to our unique context. We can't simply replicate Western processes; we must develop systems that address our specific needs and challenges.”- Mr Sanjay Aggarwal, Adviser, Department of Expenditure, Ministry of Finance, GoI

"Value-Based Procurement (VBP) emphasizes outcomes, reduced care costs, and long-term benefits. In India, VBP faces challenges like low awareness, high expenses, and limited data. Overcoming these is key to improving healthcare." – Dr. Vibhav Garg, Boston Scientific India Pvt Ltd

“We are continuously refining our regulations based on industry needs and welcome input from MedTech industry stakeholders. Together, we can create a more effective and responsive regulatory environment.”-Mr Ravindra Pratap Singh,Jt Secretary,DoP,Ministry of Chemicals&Fertilizers

“Effective technology transfer and robust R&D are essential to expand our global footprint. Adhering to global standards in clinical trials and regulatory work is crucial and will influence the global adoption of our products.”-Mr Shishir Agarwal, President & MD, Terumo India

“Leveraging human capital through skilling and focusing on R&D is crucial for India to be part of the global value chain.” Mr Hariharan Subramaniam, Co-Chairman, CII National Medical Technology Forum & Managing Director, Siemens Healthineers

“India's intellectual capacity is a key advantage. Increasing accessibility should be the primary goal. Factors like adverse event reporting, incentives for R&D and manufacturing are hallmarks of robust system.”-Mr Madan R Krishnan, VP & MD India, Boston Scientific India Pvt. Ltd

“CII can play a pivotal role in integrating industries with BIS, as no regulation succeeds without industry involvement.”- Mr Unnikrishnan A R, Scientist G, Head (Medical Equipment and Hospital Planning Department), Bureau of Indian Standards

“We are prioritizing product standards, with an even greater emphasis on process standards. Checklists for safety and performance of MedTech devices are our focus to ensure quality and reliability.”- Mr Aseem Sahu, Deputy Drug Controller (I), CDCSO

"Y-Break Session for Confederation of Indian Industry Staff" Starting today CII has introduced a biweekly session of a 15-minute virtual Chair Yoga Break to promote workplace well-being and work-life balance. This initiative is in collaboration with Kaivalyadhama Yoga Institute

"Pursue Growth & Innovation at the 6th CII Pharma & Life Sciences Summit !" 📌Date: 9 October 2024, New Delhi 🔔Register Now! cam.mycii.in/ORNew/Registra… CII Live Department of Pharmaceuticals 🇮🇳 Department of Biotechnology #lifesciences #HealthcareInnovation #CRO #CDMO #biologics #biosimilars #vaccines

Meet our keynote speaker! Dr. Jitendra Singh, MoS Science & Technology addressing the 6thCII Pharma & Life Sciences Summit 2024 in New Delhi 🔔Join us and Register Today! cam.mycii.in/ORNew/Registra… #lifesciences #biotech #HealthcareInnovation #biologics #biosimilars #vaccine

Join us at the 5th CII Public Health Summit 2023, on 7 October 2024 at Silver Oak, India Habitat Centre, New Delhi and be a part of gathering of public health specialists, innovators, technocrats, intellectuals, and healthcare business leaders. Register: lnkd.in/gzabtdBi

The Inaugural Session of #REINVEST2024 is about to begin! Tune in to hear Hon'ble Prime Minister of India, Shri Narendra Modi Ji, deliver the keynote address. Watch live : youtube.com/live/hU2UhQ4Y5… #RenewableEnergy #InvestInIndia #SustainableFuture #REInvestIndia #REInvest2024

Celebrating 100 days of #Modi3.0 . A new chapter of progress and transformation. From key policy advancements to bold reforms, here's to the journey of building a stronger, more resilient India. 🇮🇳✨ #100DaysOfModi3 #IndiaProgress

Join us for an intriguing session where Industry leaders will deliberate on the future of Pharma & Life Sciences industry. 🔔Register Now! cam.mycii.in/ORNew/Registra… #lifesciences #biotech #pharma #HealthcareInnovation #biologics #biosimilars #vaccine #CII4INDIA #cii4health